GR-55562

GR-55562
Clinical data
Other namesGR55562; GR-55,562; GR55,562
Drug classSerotonin 5-HT1B and 5-HT1D receptor antagonist; Selective serotonin 5-HT1B antagonist
Identifiers
  • 3-[3-(dimethylamino)propyl]-4-hydroxy-N-(4-pyridin-4-ylphenyl)benzamide
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H25N3O2
Molar mass375.472 g·mol−1
3D model (JSmol)
  • CN(C)CCCC1=C(C=CC(=C1)C(=O)NC2=CC=C(C=C2)C3=CC=NC=C3)O
  • InChI=1S/C23H25N3O2/c1-26(2)15-3-4-19-16-20(7-10-22(19)27)23(28)25-21-8-5-17(6-9-21)18-11-13-24-14-12-18/h5-14,16,27H,3-4,15H2,1-2H3,(H,25,28)
  • Key:ZAGAUUVCYGSPBP-UHFFFAOYSA-N

GR-55562 is a selective serotonin 5-HT1B and 5-HT1D receptor antagonist. It is one of several selective serotonin 5-HT1B receptor antagonists used in scientific research.

The drug is a silent antagonist of the serotonin 5-HT1B receptor, unlike the related agent GR-127935. GR-55562 has around 10-fold selectivity for the serotonin 5-HT1B receptor over the serotonin 5-HT1D receptor and has only weak affinity for a number of other serotonin receptors.

It is ineffective in attenuating MDMA-induced prosocial behavior in animals. Conversely, the serotonin 5-HT1A receptor antagonist WAY-100635 can abolish MDMA-induced prosocial behavior.

See also